<DOC>
	<DOCNO>NCT03081845</DOCNO>
	<brief_summary>This multiple-sites , double-blinded , randomize , control , parallel-designed , cross-over study among healthy preschooler 5 day consumption A2 A1 milk compare effect gut inflammation , gastrointestinal symptom behavioral well-being .</brief_summary>
	<brief_title>A1 Versus A2® Milk Gastrointestinal Physiology , Symptoms Cognitive Behaviour Preschool Children</brief_title>
	<detailed_description>Gut inflammation reflect serum C-Reactive Protein ( CRP ) , hemoglobin ( HB ) , interleukin-4 ( IL-4 ) , Immunoglobulin G ( IgG ) , Immunoglobulin E ( IgE ) , Immunoglobulin G1 ( IgG1 ) , Immunoglobulin G2a ( IgG2a ) , β-Casomorphin-7 ( BCM-7 ) , Glutathione , calcium ( Ca ) , iron ( Fe ) zinc ( Zn ) concentration ; gastrointestinal ( GI ) symptom measure via Visual Analog Scale ( VAS ) gut tolerance , include borborygmus , bloating , break wind , abdominal pain , diarrhea ; behavioral well-being assess use Subtle Cognitive Impairment Test ( SCIT ) . The total duration study 24 week , include subject enrollment , study intervention , laboratory testing , provide clinical study report . The cross-over study consist 5 day product intervention ; 10 day wash-out phase 1 phase 2 , respectively ; follow 6 week statistical analysis clinical report completion .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<criteria>Nonregular milk drinker ; Suffered mild moderate milk intolerance ; Agree take medication , supplement , nutrition dairy product include acidophilus milk ; Parent ( ) legal guardian 's consent study willing comply study procedure ; Parent ( ) guardian infant agree enroll infant another clinical study participate study ; Fully understand nature , objective , benefit potential risk side effect study . Have know dairy allergy ; Suffered severe milk intolerance ; Unable give write informed consent ; Use antibiotic time screening , past two week ; Have history fecal impaction ; Trying lose weight follow diet exercise regimen design weight loss , take drug influence appetite drug weight loss last three month ; Have participate similar dairy probioticscontaining product 's clinical trial within 3 month screen ; Currently take medicine cardiovascular metabolic disease ; Have history diagnose follow disease may affect study result : gastrointestinal disorder , hepatopathy , nephropathy , endocrine disease , blood disorder , respiratory cardiovascular disease ; Currently suffer gastrointestinal disorder gastrointestinal disease , include limited : irritable bowel syndrome , colitis , ulcerative colitis , celiac disease , irritable bowel syndrome ( IBS ) ; Had hospitalization within 3 month screen ; According investigator 's judgment , current frequent user drug may affect gastrointestinal function immune system .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>